Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
X4 Pharmaceuticals, Inc. (XFOR) had Earnings per Share (EPS) (Basic) of $-0.16 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.71M |
|
$-20.24M |
|
$0.60M |
|
$2.11M |
|
$23.01M |
|
$-20.31M |
|
$0.07M |
|
$-20.24M |
|
$-20.24M |
|
$-20.24M |
|
$-20.24M |
|
$-20.24M |
|
$-20.24M |
|
$-20.31M |
|
$-20.08M |
|
126.29M |
|
126.29M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.16 |
$-0.16 |
|
| Balance Sheet Financials | |
$241.98M |
|
$0.15M |
|
$28.30M |
|
$270.28M |
|
$23.77M |
|
$76.52M |
|
$78.06M |
|
$101.83M |
|
$168.45M |
|
$142.04M |
|
$168.45M |
|
94.32M |
|
| Cash Flow Statement Financials | |
$-19.60M |
|
$19.25M |
|
$0.00M |
|
$217.85M |
|
$217.49M |
|
$-0.36M |
|
$2.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.18 |
|
-- |
|
-- |
|
0.31 |
|
0.45 |
|
77.92% |
|
-749.85% |
|
-749.85% |
|
-- |
|
-747.45% |
|
-747.45% |
|
$-19.60M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.13 |
|
2.43 |
|
36.99 |
|
-12.02% |
|
-14.25% |
|
-7.49% |
|
-8.26% |
|
$1.79 |
|
$-0.16 |
|
$-0.16 |
|